Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

RPPA-Profiling in Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia Identifies Protein Patterns Associated with Outcome

Fieke W Hoff, Lourdes Sriraja, Yihua Qiu, Gaye Jenkins, Andrew Ligeralde, David T. Teachey, Brent L. Wood, Meenakshi Devidas, Mignon L. Loh, Todd A. Alonzo, Amina A Qutub, Evangelia Petsalaki, Steven M. Kornblau, Terzah M. Horton

Blood (2022) 140 (Supplement 1): 6352–6353.

https://doi.org/10.1182/blood-2022-163881

Published: 2022

Journal Articles

Proteomic Landscape of Acute Leukemia: A Comparison between ALL and AML in Adults

Fieke W Hoff, BSc, Yihua Qiu, Wendy Hu, PhD, Amina A Qutub, PhD, Eveline S. de Bont, MD PhD, Terzah M Horton, MD PhD, Steven M. Kornblau, MD

Blood (2019) 134 (Supplement_1): 1461.

https://doi.org/10.1182/blood-2019-123470

Published: 2019

Journal Articles

Signatures of Histone Modification Marks and Proteins in Pediatric Acute Myeloid Leukemia: A Comparison to Adults

Anneke D. Van Dijk, Fieke W Hoff, Eveline S. de Bont, MD PhD, YIHUA QIU, Chenyue W. Hu, Amina A Qutub, PhD, Terzah M. Horton, MD PhD, Steven M. Kornblau, MD

Blood (2018) 132 (Supplement 1): 2761.

https://doi.org/10.1182/blood-2018-99-110475

Published: 2018

Journal Articles

RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia

Fieke W Hoff, BSc, Wendy Hu, PhD, Yihua Qiu, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD, E. Anders Kolb, MD, Todd A Alonzo, PhD, Amina A Qutub, PhD, Eveline S. de Bont, MD, Sophia W.M. Bruggeman, PhD, Steven M. Kornblau, MD, Terzah M. Horton, MD PhD

Blood (2018) 132 (Supplement 1): 293.

https://doi.org/10.1182/blood-2018-99-110730

Published: 2018

Journal Articles

Proteomic Landscape of De Novo Pediatric Acute Myeloid Leukemia

Fieke W Hoff, BSc, Yihua Qiu, Wendy Hu, PhD, Amina A Qutub, PhD, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD, E. Anders Kolb, MD, Todd A Alonzo, PhD, Eveline S. de Bont, MD, Terzah M. Horton, MD PhD, Steven M. Kornblau, MD

Blood (2018) 132 (Supplement 1): 294.

https://doi.org/10.1182/blood-2018-99-110796

Published: 2018

Journal Articles

Adhesion Signaling States in AML

Chenyue W Hu, Amina A Qutub, PhD, Yihua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Naval G. Daver, MD, Maro Ohanian, DO, Kevin Coombes, PhD, Steven M. Kornblau, MD

Blood (2014) 124 (21): 2386.

https://doi.org/10.1182/blood.V124.21.2386.2386

Published: 2014

Journal Articles

CREB/ATF Family Protein Expression States in AML: Active CREB1, but Not ATF Is an Adverse Prognostic Factor

Steven M. Kornblau, MD, Chenyue W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Kavita Chauhan, Elias Jabbour, MD, Farhad Ravandi, MD, Kevin Coombes, PhD, Amina A Qutub, PhD

Blood (2014) 124 (21): 2344.

https://doi.org/10.1182/blood.V124.21.2344.2344

Published: 2014

Journal Articles

Expression of Ribosomal Protein S6 (R6SP) and Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (EIF4EBP1) Is Correlated in Acute Myelogenous Leukemia (AML) and Is Highly Prognostic, Especially in NPM1 and FLT3 Wildtype Patients

Steven M. Kornblau, MD, Chenyue W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Rebecca A Murray, Nitin Jain, MD, Yesid Alvarado, MD, Kevin Coombes, PhD, Amina A Qutub, PhD

Blood (2014) 124 (21): 2369.

https://doi.org/10.1182/blood.V124.21.2369.2369

Published: 2014

Journal Articles

Heatshock Protein (HSP) Family Expression Is Dichotomous and Prognostic in Acute Myelogenous Leukemia (AML)

Steven M. Kornblau, MD, Chenyue W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Trang T Nguyen, Tapan Kadia, MD, Gautam Borthakur, MD, Kevin Coombes, PhD, Amina A Qutub, PhD

Blood (2014) 124 (21): 1026.

https://doi.org/10.1182/blood.V124.21.1026.1026

Published: 2014

Journal Articles

Standard Proteomic Analysis (SPA) in AML: An Integrated Procedure for Discovering Hypoxia and Angiogenesis Patterns

Chenyue W Hu, Steven M. Kornblau, MD, Alex Bisberg, Amina A Qutub, PhD

Blood (2014) 124 (21): 1056.

https://doi.org/10.1182/blood.V124.21.1056.1056

Published: 2014

Journal Articles

Recurrent Patterns Of Histone Methylation and Acetylation Regulating Protein Expression In Acute Myelogenous Leukemia (AML)

Steven M. Kornblau, MD, Chenyu W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Amina A Qutub, PhD, Kevin R. Coombes, PhD

Blood (2013) 122 (21): 3733.

https://doi.org/10.1182/blood.V122.21.3733.3733

Published: 2013

Journal Articles

Hippo Pathway (HP) Activity In Acute Myelogenous Leukemia (AML): Different Prognostic Implications Of TAZ versus YAP Inactivation By Phosphorylation

Steven M. Kornblau, MD, Chenyu W Hu, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Tapan M. Kadia, MD, Alessandra Ferrajoli, MD, Kevin R. Coombes, PhD, Amina A Qutub, PhD

Blood (2013) 122 (21): 1337.

https://doi.org/10.1182/blood.V122.21.1337.1337

Published: 2013

Journal Articles

Classification Of Acute Myelogenous Leukemia (AML) Based On Functionally Related Proteins Groups

Steven M. Kornblau, MD, Chenyu W Hu, Suk Young Yoo, PhD, Yihua Qiu, MD, Nianxiang Zhang, PhD, Gautam Borthakur, MD, Naval G. Daver, MD, Amina A Qutub, PhD, Kevin R. Coombes, PhD

Blood (2013) 122 (21): 492.

https://doi.org/10.1182/blood.V122.21.492.492

Published: 2013

Journal Articles

A Global Proteomic Pathway Map In Acute Myeloid Leukemia (AML)

Chenyu W Hu, Amina A Qutub, PhD, Yihua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Naveen Pammaraju, MD, Courtney D. DiNardo, MD, Kevin R. Coombes, PhD, Steven M. Kornblau, MD

Blood (2013) 122 (21): 1302.

https://doi.org/10.1182/blood.V122.21.1302.1302

Published: 2013

Journal Articles

Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia

Steven M. Kornblau, Yi Hua Qiu, Nianxiang Zhang, Neera Singh, Stefan Faderl, Alessandra Ferrajoli, Heather York, Amina A. Qutub, Kevin R. Coombes, Dennis K. Watson

Blood (2011) 118 (20): 5604–5612.

https://doi.org/10.1182/blood-2011-04-348052

Published: 2011

Includes: Supplemental data

NARROW

RPPA-Profiling in Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia Identifies Protein Patterns Associated with Outcome

Proteomic Landscape of Acute Leukemia: A Comparison between ALL and AML in Adults

Signatures of Histone Modification Marks and Proteins in Pediatric Acute Myeloid Leukemia: A Comparison to Adults

RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia

Proteomic Landscape of De Novo Pediatric Acute Myeloid Leukemia

Adhesion Signaling States in AML

CREB/ATF Family Protein Expression States in AML: Active CREB1, but Not ATF Is an Adverse Prognostic Factor

Expression of Ribosomal Protein S6 (R6SP) and Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (EIF4EBP1) Is Correlated in Acute Myelogenous Leukemia (AML) and Is Highly Prognostic, Especially in NPM1 and FLT3 Wildtype Patients

Heatshock Protein (HSP) Family Expression Is Dichotomous and Prognostic in Acute Myelogenous Leukemia (AML)

Standard Proteomic Analysis (SPA) in AML: An Integrated Procedure for Discovering Hypoxia and Angiogenesis Patterns

Recurrent Patterns Of Histone Methylation and Acetylation Regulating Protein Expression In Acute Myelogenous Leukemia (AML)

Hippo Pathway (HP) Activity In Acute Myelogenous Leukemia (AML): Different Prognostic Implications Of TAZ versus YAP Inactivation By Phosphorylation

Classification Of Acute Myelogenous Leukemia (AML) Based On Functionally Related Proteins Groups

A Global Proteomic Pathway Map In Acute Myeloid Leukemia (AML)

Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only